SCM
MEDP icon

Spyglass Capital Management’s Medpace MEDP Stock Holding History

Spyglass Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.7M Buy
120,365
+64,610
+116% +$29.8M 3.45% 17
2026
Q1 		$26.8M Sell
55,755
-13,420
-19% -$6.87M 1.9% 24
2025
Q4 		$38.9M Sell
69,175
-81,707
-54% -$46.4M 1.94% 25
2025
Q3 		$77.6M Sell
150,882
-73,589
-33% -$32.1M 4.14% 13
2025
Q2 		$70.5M Sell
224,471
-17,675
-7% -$5.31M 4.16% 10
2025
Q1 		$73.8M Sell
242,146
-20,514
-8% -$6.9M 5.07% 6
2024
Q4 		$87.3M Buy
262,660
+120,778
+85% +$41M 4.91% 7
2024
Q3 		$47.4M Buy
141,882
+32,466
+30% +$12.3M 3.11% 19
2024
Q2 		$45.1M Sell
109,416
-1,395
-1% -$552K 3.3% 17
2024
Q1 		$44.8M Sell
110,811
-40,918
-27% -$14.4M 2.98% 20
2023
Q4 		$46.5M Sell
151,729
-7,544
-5% -$2.04M 3.35% 21
2023
Q3 		$38.6M Buy
159,273
+16,636
+12% +$4.25M 3.02% 20
2023
Q2 		$34.3M Buy
142,637
+98,456
+223% +$20.5M 2.48% 23
2023
Q1 		$8.31M Buy
+44,181
New +$9.14M 0.63% 25

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Spyglass Capital Management's MEDP Position: Q2 2026 in Review

Spyglass Capital Management increased its Medpace (MEDP) stake by 116% in Q2 2026, buying an estimated $29.8M and bringing the position to 120,365 shares worth $63.7M. The position accounts for 3.45% of the portfolio, ranked #17.

Spyglass Capital Management first reported a position in MEDP in Q1 2023 and has held it in 14 quarters since. The position peaked at $87.3M in Q4 2024. 699 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Spyglass Capital Management held 120,365 shares of Medpace worth $63.7M as of Q2 2026.
  • Spyglass Capital Management bought 64,610 Medpace shares in Q2 2026, an estimated $29.8M.
  • Medpace made up 3.45% of Spyglass Capital Management's portfolio in Q2 2026, its #17 holding.
  • Spyglass Capital Management first reported a position in Medpace in Q1 2023 and has held it in 14 quarters since.
  • Spyglass Capital Management's Medpace position peaked at $87.3M in Q4 2024.
  • 699 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Spyglass Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.